Teva secures $34 billion financing for Allergan acquisition
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has entered into commitment letters relating to its pending acquisition of Allergan’s generic pharmaceuticals business with Bank of America More...
Teva buys Allergan Generics for $40.5 billion
Following a report in the “Wall Street Journal” of negotiations on the deal, and the suspension of trading in Teva stock on the Tel Aviv Stock exchange this morning, Teva Pharmaceutical More...
Teva rejected opportunity to acquire Perrigo
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) had an opportunity to acquire US pharmaceuticals company Perrigo Company (NYSE:PRGO; TASE:PRGO) a few months ago, and said it was not interested, More...
Tamir Capital soars after court ruling against Teva
Shares in Tamir Capital are soaring on lively volumes, following a Tel Aviv District Court ruling that Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) infringed the terms of a license from Proneuron More...
Teva to pay $512 million in Provigil settlement – report
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has agreed to pay $512 million to settle a class action suit, reports “Reuters.” The class action claims that Cephalon Inc., More...
Teva to Distribute Eagle Pharmaceutical’s Cancer Drug in U.S
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) have entered into an exclusive license agreement for EP-3102, Eagle’s bendamustine hydrochloride More...
Teva buying back $1Billion of debt
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) announced today that was making tender offers for its bonds to the tune of $1 billion, with the aim of reducing its finance costs. The company More...
US Supreme Court upholds Copaxone patent
The ruling means Teva’s flagship multiple sclerosis treatment’s patent remains valid until September 2015. The US Supreme Court has ruled in favor of Teva Pharmaceutical Industries Ltd. (NYSE: More...
Perrigo good acquisition candidate for Teva – report
Bloomberg reports that increased competition with cheaper generics may push Teva to make a major acquisition soon. Perrigo Company (NYSE:PRGO; TASE:PRGO) may be a suitable acquisition for Teva Pharmaceutical More...
FDA approves Teva allergy spray for children
– The QNASL nasal spray, approved in 2012 for adults, treats nasal symptoms of allergic rhinitis, including hay fever, in children. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) More...